Prostate Cancer Screening Explained

Prostate cancer screening involves tests that look for signs of cancer before symptoms appear. The prostate is a walnut-sized gland that sits below the bladder in men. Understanding screening options helps men make informed decisions with their healthcare providers.

Screening for prostate cancer has both benefits and risks. Cancer screening can find cancer early when treatment may be more effective. However, not all prostate cancers need immediate treatment, which makes screening decisions more complex than for some other cancers.

Types of Prostate Cancer Screening Tests

The two main screening tests for prostate cancer are the PSA blood test and the digital rectal exam (DRE). The PSA test measures prostate-specific antigen levels in the blood. PSA is a protein made by both normal and cancerous prostate cells.

During a DRE, a healthcare provider examines the prostate through the rectum. They check for lumps, hard areas, or other unusual features. This exam takes only a few minutes and is often done along with the PSA test.

Some men may also have imaging tests like MRI if screening results suggest further evaluation is needed. These additional tests help doctors get a clearer picture of the prostate and any areas of concern.

Understanding PSA Test Results

PSA levels are measured in nanograms per milliliter (ng/mL) of blood. There is no single “normal” PSA level that applies to all men. PSA levels naturally increase with age, and what is considered normal varies by age group.

Higher PSA levels may suggest prostate cancer, but many other conditions can also raise PSA. These include benign prostatic hyperplasia (enlarged prostate), prostatitis (prostate inflammation), and recent medical procedures. Research shows that about 75% of men with elevated PSA do not have cancer.

Healthcare providers consider PSA trends over time, not just single test results. A rapid rise in PSA levels may be more concerning than a stable elevated level. Some doctors use PSA density calculations that account for prostate size when interpreting results.

Who Should Consider Screening

Screening recommendations vary among medical organizations. The American Cancer Society suggests men discuss screening starting at age 50 for average risk, age 45 for high risk, and age 40 for very high risk groups.

Men at higher risk include African American men and those with close relatives who had prostate cancer. Studies suggest these groups develop prostate cancer at younger ages and may have more aggressive forms of the disease.

Men with a life expectancy of less than 10 years are generally not recommended for screening. This is because prostate cancer often grows slowly, and screening may not improve outcomes for men with serious health conditions or advanced age.

The decision should be made individually after discussing benefits and risks with a healthcare provider. Early detection can be lifesaving for some men, while others may experience unnecessary worry and procedures.

Benefits and Limitations of Screening

Prostate cancer screening can detect cancer in its early stages when treatment options may be more effective. The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial found that PSA screening reduced prostate cancer deaths by about 25% over 13 years of follow-up.

However, screening also has important limitations. Many prostate cancers grow very slowly and may never cause health problems. Studies suggest that up to 50% of screen-detected cancers might never have caused symptoms during a man’s lifetime.

Overdiagnosis can lead to overtreatment, where men receive surgery or radiation for cancers that would not have harmed them. Treatment side effects can include incontinence, erectile dysfunction, and bowel problems that significantly impact quality of life.

False positive results are also common. This means the test suggests cancer when none is present, leading to anxiety and additional testing including biopsies that carry their own risks.

What Happens After Abnormal Results

An elevated PSA or abnormal DRE does not mean cancer is present. Healthcare providers typically recommend additional testing to determine if cancer is actually present. This may include repeating the PSA test, especially if it was the first time being tested.

If PSA remains elevated, doctors may recommend a prostate biopsy. During this procedure, small tissue samples are removed from the prostate using a thin needle. The samples are examined under a microscope to check for cancer cells.

Newer approaches include multiparametric MRI before biopsy. This imaging can help identify suspicious areas and may reduce the need for biopsies in some men. Some doctors also use additional blood or urine tests to help assess cancer risk more accurately.

If cancer is found, additional tests determine the stage and grade. This information helps doctors and patients decide on the best treatment approach, which may include active surveillance for low-risk cancers.

Preparing for Prostate Cancer Screening

Men can take several steps to prepare for prostate cancer screening. Preparing for screening includes avoiding activities that might temporarily raise PSA levels before testing.

Vigorous exercise, bicycle riding, or sexual activity within 48 hours before testing may elevate PSA levels. Some medications and supplements can also affect results, so men should discuss all medications with their healthcare provider.

It helps to bring a list of questions to the appointment. Men should ask about their individual risk factors, what the test results mean, and what follow-up might be needed. Understanding the testing process reduces anxiety and helps with decision-making.

Keeping track of previous PSA results allows healthcare providers to see trends over time. Men should request copies of test results and bring them to future appointments with different providers.

Common Myths and Misunderstandings

Myth: A High PSA Always Means Cancer

Many men believe that an elevated PSA test automatically means they have prostate cancer. In reality, numerous non-cancerous conditions can raise PSA levels, including enlarged prostate, prostate infections, and even recent physical activity. Studies show that most men with elevated PSA levels do not have cancer.

Myth: Normal PSA Means No Cancer Risk

Some men assume that a normal PSA level guarantees they do not have prostate cancer. However, about 15% of men with normal PSA levels may still have prostate cancer, and some aggressive cancers do not produce high PSA levels. This is why healthcare providers consider multiple factors, not just PSA results.

Myth: All Prostate Cancers Need Immediate Treatment

Many people believe that finding prostate cancer always requires immediate surgery or radiation. Research shows that many prostate cancers grow very slowly and may never threaten a man’s life. Active surveillance, where doctors carefully monitor low-risk cancers, is now a standard option for many men.

Key Takeaways

• Prostate cancer screening uses PSA blood tests and digital rectal exams to look for signs of cancer before symptoms appear
• PSA levels can be elevated for many reasons besides cancer, including benign prostate enlargement and infections
• Screening decisions should be individualized based on age, risk factors, overall health, and personal preferences
• Benefits include early detection of potentially life-threatening cancers, while risks include overdiagnosis and overtreatment
• Abnormal screening results require additional testing, often including prostate biopsy, to determine if cancer is present
• Men should discuss screening benefits and risks with their healthcare providers to make informed decisions

Learn More

• National Cancer Institute – Prostate Cancer Screening – Comprehensive overview of screening methods and recommendations
• CDC – Prostate Cancer Screening – Basic information about prostate cancer screening tests and guidelines
• U.S. Preventive Services Task Force – Prostate Cancer Screening – Evidence-based screening recommendations and rationale
• National Cancer Institute – PSA Test Fact Sheet – Detailed information about PSA testing and result interpretation
• CDC – Prostate Cancer Risk Factors – Information about factors that increase prostate cancer risk
• ClinicalTrials.gov – Prostate Cancer Screening Studies – Current research studies on prostate cancer screening methods
• National Cancer Institute – Understanding Screening Statistics – How to interpret screening test accuracy and outcomes

Disclaimer: This information is for educational purposes only and is not medical advice. Talk to a healthcare provider about questions related to your health.